指南与共识心脑血管急症重症综合管理与镇静镇痛儿科与产科急症

儿童烟雾病血运重建围手术期管理:改良德尔菲研究

Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.
PubMed 文献 · Neurocrit Care · 2023-07-20
一句话结论专家共识:儿童烟雾病间接血运重建术前4小时至术后24小时输注等渗液体、围术期不停用阿司匹林、术后至少24小时监测血压并避免低血压。

该研究采用三轮改良德尔菲法,邀请北美30名在儿童烟雾病管理方面具有专长的神经内科、神经外科和重症监护医生参与,通过138项实践模式调查、对88条共识声明的5点李克特量表匿名电子评估以及虚拟小组会议,最终就儿童烟雾病间接血运重建围术期护理达成39条共识。共识要点包括:高卒中风险及镰状细胞病患儿应术前收住院;所有患者术前至少4小时至术后24小时静脉输注等渗液体;围术期不停用阿司匹林;术后至少24小时继续动脉置管监测血压直至无需主动干预达标;术后至少24小时每小时监测生命体征、至少12小时每小时神经系统评估、充分镇痛、维持正常氧合与体温、避免低血压;新发局灶性神经功能缺损首选静脉液体推注。研究还确定了术后持续脑电图监测的作用、最佳围术期血压和血红蛋白目标以及疑似术后缺血补充氧疗的作用等未来研究方向。

要点

  • 所有患儿术前至少4小时至术后24小时静脉输注等渗液体;高卒中风险及镰状细胞病患儿应术前收住院。
  • 阿司匹林在术前和术后近期不应停用。
  • 术后动脉置管监测血压应持续至少24小时,直至无需主动干预即可达到血压目标。
  • 术后至少24小时每小时监测生命体征、至少12小时每小时神经系统评估,充分镇痛、维持正常氧合与体温、避免低血压。
  • 间接血运重建术后新发局灶性神经功能缺损,可考虑静脉液体推注作为一线干预。

适用人群与场景

  • 接受间接血运重建手术的儿童烟雾病动脉病患者。
  • 高卒中风险及镰状细胞病患儿应术前收住院。

诊断标准与关键阈值

  • 共识定义为≥80%同意或不同意。

处置流程与药物剂量

  • 所有患者术前至少4小时至术后24小时静脉输注等渗液体。
  • 术前和术后近期不应停用阿司匹林。
  • 术后动脉置管监测血压应持续至少24小时,直至无需主动干预即可达到血压目标。
  • 术后至少24小时每小时监测生命体征,至少12小时每小时神经系统评估,充分镇痛,维持正常氧合与体温,避免低血压。
  • 间接血运重建术后新发局灶性神经功能缺损,可考虑静脉液体推注作为一线干预。

红旗征与不能漏的情况

  • 间接血运重建术后新发局灶性神经功能缺损,可考虑静脉液体推注作为一线干预。

研究设计与关键结果

  • 三轮改良德尔菲法:30名北美儿童烟雾病专家参与,包括138项实践模式调查、88条共识声明的5点李克特量表匿名电子评估及虚拟小组会议,最终39条声明达成共识。

证据类型、等级与局限

  • 证据类型:改良德尔菲专家共识。
  • 共识定义:≥80%同意或不同意。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在缺乏支持儿童烟雾病间接血运重建围术期特定护理实践数据的情况下,本德尔菲过程在具有烟雾病专长的神经外科、神经内科和重症监护医生中定义了共识领域。
  • 未来研究重点包括:确定术后持续脑电图监测在烟雾病护理中的作用、最佳围术期血压和血红蛋白目标,以及补充氧疗治疗疑似术后缺血的作用。

指南或共识出处

  • 儿童烟雾病血运重建围术期管理:改良德尔菲研究(Neurocrit Care)。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Surgical revascularization decreases the long-term risk of stroke in children with moyamoya arteriopathy but can be associated with an increased risk of stroke during the perioperative period. Evidence-based approaches to optimize perioperative management are limited and practice varies widely. Using a modified Delphi process, we sought to establish expert consensus on key components of the perioperative care of children with moyamoya undergoing indirect revascularization surgery and identify areas of equipoise to define future research priorities.

METHODS: Thirty neurologists, neurosurgeons, and intensivists practicing in North America with expertise in the management of pediatric moyamoya were invited to participate in a three-round, modified Delphi process consisting of a 138-item practice patterns survey, anonymous electronic evaluation of 88 consensus statements on a 5-point Likert scale, and a virtual group meeting during which statements were discussed, revised, and reassessed. Consensus was defined as ≥ 80% agreement or disagreement.

RESULTS: Thirty-nine statements regarding perioperative pediatric moyamoya care for indirect revascularization surgery reached consensus. Salient areas of consensus included the following: (1) children at a high risk for stroke and those with sickle cell disease should be preadmitted prior to indirect revascularization; (2) intravenous isotonic fluids should be administered in all patients for at least 4 h before and 24 h after surgery; (3) aspirin should not be discontinued in the immediate preoperative and postoperative periods; (4) arterial lines for blood pressure monitoring should be continued for at least 24 h after surgery and until active interventions to achieve blood pressure goals are not needed; (5) postoperative care should include hourly vital signs for at least 24 h, hourly neurologic assessments for at least 12 h, adequate pain control, maintaining normoxia and normothermia, and avoiding hypotension; and (6) intravenous fluid bolus administration should be considered the first-line intervention for new focal neurologic deficits following indirect revascularization surgery.

CONCLUSIONS: In the absence of data supporting specific care practices before and after indirect revascularization surgery in children with moyamoya, this Delphi process defined areas of consensus among neurosurgeons, neurologists, and intensivists with moyamoya expertise. Research priorities identified include determining the role of continuous electroencephalography in postoperative moyamoya care, optimal perioperative blood pressure and hemoglobin targets, and the role of supplemental oxygen for treatment of suspected postoperative ischemia.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Sun LR, Jordan LC, Smith ER, et al. Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study. Neurocrit Care. 2023. PMID: 37470933. doi:10.1007/s12028-023-01788-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。